These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 5749656)

  • 41. Assessment of the future resources and needs for hospitalization in Hong Kong SAR (Special Administrative District).
    Yip PS; Law CK
    Int J Health Plann Manage; 2002; 17(2):113-22. PubMed ID: 12126208
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Global leprosy statistics: a cause for pride, or frustration?
    Fine PE
    Lepr Rev; 2006 Dec; 77(4):295-7. PubMed ID: 17343216
    [No Abstract]   [Full Text] [Related]  

  • 43. Further observations on streptomycin combined with sulfones in relapsed lepromatous leprosy.
    Hastings RC; Trautman JR; Mansfield RE
    Int J Lepr Other Mycobact Dis; 1969; 37(2):130-4. PubMed ID: 5389014
    [No Abstract]   [Full Text] [Related]  

  • 44. Orbital development in Hong Kong Chinese subjects.
    Chau A; Fung K; Yip L; Yap M
    Ophthalmic Physiol Opt; 2004 Sep; 24(5):436-9. PubMed ID: 15315658
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Sulfone resistance and leprosy control.
    Lechat MF
    Int J Lepr Other Mycobact Dis; 1978; 46(1):65-7. PubMed ID: 565757
    [No Abstract]   [Full Text] [Related]  

  • 46. Protective effect of BCG against leprosy and its subtypes: a case-control study in southern Vietnam.
    Thuc NV; Abel L; Lap VD; Oberti J; Lagrange PH
    Int J Lepr Other Mycobact Dis; 1994 Dec; 62(4):532-8. PubMed ID: 7868950
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Trends in prevalence and case finding in the ALERT leprosy control programme, 1979-1999.
    Groenen G
    Lepr Rev; 2002 Mar; 73(1):29-40. PubMed ID: 11969124
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Disabilities in leprosy.
    Kalla G; Kachhawa D; Salodkar A
    Int J Lepr Other Mycobact Dis; 2000 Jun; 68(2):182-4. PubMed ID: 11036502
    [No Abstract]   [Full Text] [Related]  

  • 49. Complex segregation analysis of leprosy in southern Vietnam.
    Abel L; Vu DL; Oberti J; Nguyen VT; Van VC; Guilloud-Bataille M; Schurr E; Lagrange PH
    Genet Epidemiol; 1995; 12(1):63-82. PubMed ID: 7713401
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A population-based survey on infant feeding practice (0-2 years) in Hong Kong: breastfeeding rate and patterns among 3,161 infants below 6 months old.
    Lee WT; Lui SS; Chan V; Wong E; Lau J
    Asia Pac J Clin Nutr; 2006; 15(3):377-87. PubMed ID: 16837431
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Adequacy and pitfalls of G6PD deficiency counseling in Hong Kong.
    Li KC; Lai SS; Lam ST
    Southeast Asian J Trop Med Public Health; 1999; 30 Suppl 2():79-83. PubMed ID: 11400793
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Immunomorphology of lepromatous leprosy].
    Kop'eva TN
    Arkh Patol; 1972; 34(4):35-41. PubMed ID: 5043685
    [No Abstract]   [Full Text] [Related]  

  • 53. Streptomycin combined with sulfones in the treatment of relapsed lepromatous leprosy.
    Hastings RC; Trautman JR
    Int J Lepr Other Mycobact Dis; 1968; 36(1):45-51. PubMed ID: 5689649
    [No Abstract]   [Full Text] [Related]  

  • 54. [Comments on 9 cases of lepromatous leprosy].
    Puissant A; Pringuet R; Pradinaud R
    Bull Soc Fr Dermatol Syphiligr; 1968; 75(1):20-6. PubMed ID: 5674296
    [No Abstract]   [Full Text] [Related]  

  • 55. Control of leprosy.
    Lechat MF
    Lepr Rev; 1969 Oct; 40(4):191-4. PubMed ID: 5385243
    [No Abstract]   [Full Text] [Related]  

  • 56. [Findings of the real value of sulphonotherapy in the programs of prevention of leprosy].
    Lima Lde S
    Rev Bras Leprol; 1968-1969; 36(1):31-6. PubMed ID: 5748409
    [No Abstract]   [Full Text] [Related]  

  • 57. A study of Hansen's disease in Ceylon.
    Heffner LT
    South Med J; 1969 Aug; 62(8):979-85. PubMed ID: 5798339
    [No Abstract]   [Full Text] [Related]  

  • 58. [Late evolutive recurrences of formerly treated leprosy].
    Merklen FP; Cottenot F; Pennec J; Blanchet P
    Bull Soc Fr Dermatol Syphiligr; 1971; 78(4):459-61. PubMed ID: 5170176
    [No Abstract]   [Full Text] [Related]  

  • 59. Patient compliance in leprosy control: a necessity in old and new regimens.
    Huikeshoven H
    Int J Lepr Other Mycobact Dis; 1985 Sep; 53(3):474-80. PubMed ID: 4045267
    [No Abstract]   [Full Text] [Related]  

  • 60. Prevention of leprosy.
    Crawford CL
    Lancet; 1971 Dec; 2(7738):1375. PubMed ID: 4108289
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.